Preterm birth (PTB) continues to pose a challenge in neonatal medicine, and it is the major cause of perinatal morbidity and ...

Researchers have identified how CBD interacts with cannabinoid receptors to mitigate the negative effects of THC, the psychoactive component of cannabis.

InMed Pharmaceuticals, a clinical stage pharmaceutical company based in Vancouver, Canada, is developing rare cannabinoid–based therapeutic drug candidates for patients who may benefit from the ...

A study by the (UPV/EHU) demonstrates that the drug WIN55,212-2 protects the brain and reverses early cognitive damage caused ...

University of Mississippi researchers have discovered how a compound found in cannabis might be used to mitigate the negative ...

More information: Luis Gustavo A. Patrone et al, Long-term effects on cardiorespiratory and behavioral responses in male and ...

Enveric's Akos Biosciences licensed its cannabinoid-COX-2 conjugate technology to Restoration Biologics for joint disease ...

Ashley started at The Scientist in 2018. Before joining the staff, she worked as a freelance editor and writer, a writer at the Simons Foundation, and a web producer at Science News, among other ...

Epidiolex is a 100 mg/ml oral solution plant-based, prescription cannabinoid-based medicine. It has been approved for use in the UK in three conditions. In July 2019, it was approved by the ...

An F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. patent details new cannabinoid CB2 receptor modulators reported to be useful for the treatment of neuropathic pain, asthma, osteoporosis, ...

Research shows that the drug activates the cannabinoid neurotransmitter system (which protects the brain), and this stimulates the cholinergic system (which controls memory and learning ...